scholarly journals 6 INFLAMMATORY BOWEL DISEASE AND PREGNANCY: PRELIMINARY RESULTS OF A EUROPEAN MULTICENTER PROSPECTIVE CASE-CONTROL STUDY

2008 ◽  
Vol 2 (1) ◽  
pp. 2-3
Author(s):  
A. Bortoli
2019 ◽  
Vol 1 (3) ◽  
Author(s):  
Jeffrey A Berinstein ◽  
Calen A Steiner ◽  
Athos Bousvaros ◽  
Felix P Tiongco ◽  
Eugene Greenberg ◽  
...  

Abstract Background Fecal calprotectin (fCAL) is a noninvasive biomarker used to differentiate between inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS). Methods A multicenter prospective case–control study evaluating the BÜHLMANN fCAL enzyme-linked immunosorbent assay (ELISA) was conducted in 478 subjects. Sensitivity, specificity, predictive values, and area under the receiver operator characteristic (AuROC) curve are reported and compared to another device. Results In differentiating IBD from IBS, the BÜHLMANN fCAL ELISA is very sensitive (93.3%) at a cutoff <80 μg/g and balanced sensitivity (84.4%) and specificity (85.4%) at a cutoff >160 μg/g (AuROC 0.933). Conclusions The BÜHLMANN fCAL ELISA demonstrates excellent discriminating between IBD and IBS.


2000 ◽  
Vol 118 (4) ◽  
pp. A1361
Author(s):  
Gottfried Novacek ◽  
Wolfgang Miehsler ◽  
Eva Valic ◽  
Wolfgang Tillinger ◽  
Walter Reinisch ◽  
...  

2001 ◽  
Vol 33 ◽  
pp. A68
Author(s):  
A. Bortoli ◽  
A. Prada ◽  
L. Beretta ◽  
L. Ferraris ◽  
M. Da Perna ◽  
...  

2001 ◽  
Vol 120 (5) ◽  
pp. A449-A449
Author(s):  
W MIEHSLER ◽  
E VALIC ◽  
W TILLINGER ◽  
W REINISCH ◽  
W OSTERODE ◽  
...  

2001 ◽  
Vol 120 (5) ◽  
pp. A449
Author(s):  
Wolfgang Pf Miehsler ◽  
Eva Valic ◽  
Wolfgang Tillinger ◽  
Walter Reinisch ◽  
Wolf Osterode ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document